相似文献
1
Is hyperbaric oxygen more effective than carbogen/nicotinamide in tumor radiation response?
Radiat Res. 1997 Nov;148(5):523-5.
2
Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide.
Radiat Res. 1997 Jun;147(6):715-20.
3
Comments on hyperbaric oxygen and carbogen/nicotinamide with fractionated radiation.
Radiat Res. 1997 Nov;148(5):526-7.
4
5
Carbogen and nicotinamide: expectations too high?
Radiother Oncol. 1992 Jun;24(2):75-6. doi: 10.1016/0167-8140(92)90281-x.
6
Carbogen and nicotinamide: expectations too high? (response to J. Martin Brown).
Radiother Oncol. 1992 Jun;24(2):121-2. doi: 10.1016/0167-8140(92)90291-2.
7
Extrapolations from laboratory and preclinical studies for the use of carbogen and nicotinamide in radiotherapy.
Radiother Oncol. 1992 Jun;24(2):123-4. doi: 10.1016/0167-8140(92)90292-3.
8
ARCON.
Strahlenther Onkol. 1996 Nov;172 Suppl 2:34-5.
9
Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
Acta Oncol. 1994;33(4):371-6. doi: 10.3109/02841869409098431.
10
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
Br J Cancer. 1993 Aug;68(2):269-73. doi: 10.1038/bjc.1993.326.
Zotero 插件